01

Sigma-Aldrich Corporation

U.S.A

Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Ranolazine

CAS Number :

Quantity Per Vial :

Sale Unit :

Price : $216.00

Details :

Monograph : PHR2676-500MG

Storage : +2°C to +30°C

Portfolio PDF

Corporate PDF

02

Sigma-Aldrich Corporation

U.S.A

Gulf Coast Conference

Booth #209

Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Ranolazine Related Compound A

CAS Number :

Quantity Per Vial :

Sale Unit :

Price : $742.00

Details :

Monograph : PHR2677-100MG

Storage : +2°C to +30°C

Portfolio PDF

Corporate PDF

03

Sigma-Aldrich Corporation

U.S.A

Gulf Coast Conference

Booth #209

Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Ranolazine Related Compound B

CAS Number :

Quantity Per Vial :

Sale Unit :

Price : $342.00

Details :

Monograph : PHR2678-100MG

Storage : +2°C to +30°C

Portfolio PDF

Corporate PDF

04

Analytic Partners, Inc

U.S.A

World Drug Safety EU

Not Confirmed

05

Aozeal Certified Standards

U.S.A

World Drug Safety EU

Not Confirmed

06

Aozeal Certified Standards

U.S.A

World Drug Safety EU

Not Confirmed

07

Clearsynth Labs Limited

India

World Drug Safety EU

Not Confirmed

08

Ningbo Zhenlei Chemical Co.,Ltd

China

World Drug Safety EU

Not Confirmed

09

Piramal Pharma Solutions

U.S.A

World Drug Safety EU

Not Confirmed

10

Shandong Focus Biotechnology Co., Ltd

China

World Drug Safety EU

Not Confirmed

Ranexa, Ranolazine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers

27 USDMF

15 EU WC

2 KDMF

22 NDC API

35 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

53 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers

58 FDA Orange Book

28 Europe

2 Canada

3 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GRANULES, EXTENDED RELEASE;ORAL - 1GM

GRANULES, EXTENDED RELEASE;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

2 Evonik

1 SPI Pharma

4 DKSH

3 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Kirsch Pharma

1 ACG Worldwide

2 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 BASF

1 Clariant

13 Corel Pharma Chem

4 DFE Pharma

10 Gangwal Chemicals

9 Ideal Cures

21 Kerry

1 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

10 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Novo Excipients

1 Pharmatrans-Sanaq

2 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

9 Roquette

12 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

2 Silverline Chemicals

2 The Dow Chemical Company

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Coating Systems & Additives

32 Fillers, Diluents & Binders

26 Controlled & Modified Release

14 Solubilizers

14 Direct Compression

14 Thickeners and Stabilizers

13 Granulation

12 Film Formers & Plasticizers

12 Lubricants & Glidants

10 Parenteral

9 Co-Processed Excipients

TABLET, EXTENDED RELEASE;ORAL - 1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons